Gecko Biomedical obtains 1.3 million euros to advance Bio-inspired Surgical Solutions

Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces today it has received 1.3 million euros from Bpifrance to advance its Bio-inspired Surgical Solutions.

The funds are part of Bpifrance's support to innovation through its Aide au Développement de l'Innovation (ADI) program, providing repayable advances to encourage the development of innovative products.

These funds will be dedicated to advancing the manufacturing scale-up of Gecko Biomedical's Liquid Film platform, and the completion of the non-clinical development plan for regulatory purposes.

Christophe Bancel, Gecko Biomedical's Chief Executive Officer said "We are truly appreciative of Bpifrance's support forour development activities. This ADI will allow us to swiftly advance the development program of Gecko Biomedical's innovative adhesives. As such, Bpifrance is a key stakeholder in our short and medium term development."

"Gecko Biomedical is a Parisian start-up whose innovation program presents multiple applications in the closure of surgical wounds in situ. In partnership with private investors, Bpifrance is delighted to support Gecko Biomedical in the development of its innovative solutions with an international appeal," comments Guillaume Poissonier, Innovation Manager from Bpifrance.